Rosuvastatin and low‐dose carvedilol combination protects against isoprenaline‐induced myocardial infarction in rats: Role of PI3K/Akt/Nrf2/HO‐1 signalling. (8th July 2021)

• Record Type: Journal Article
• Authors: Baraka, Sarah A.; Tolba, Mai F.; Elsherbini, Doaa A.; El‐Naga, Reem N.; Awad, Azza S.; El‐Demerdash, Ebtehal
• Is Part Of: Clinical and experimental pharmacology and physiology. Volume 48:Number 10(2021)
• Page Start: 1358
• Page End: 1370
• Publication Date: 2021-07-08
• Subjects: Carvedilol -- isoproterenol -- myocardial infarction -- PI3K/Akt/Nrf2/HO‐1 -- rosuvastatin; Clinical pharmacology -- Periodicals; Pharmacology, Experimental -- Periodicals; Physiology, Experimental -- Periodicals; Physiology, Pathological -- Periodicals; 615.1
• DOI: 10.1111/1440-1681.13535
• Languages: English
• ISSNs: 0305-1870

Abstract

Abstract: Rosuvastatin has been shown to activate PI3K/Akt/Nrf2/HO‐1 pathway, which promotes cell survival in the myocardium. This study investigated the therapeutic benefit of adding rosuvastatin to low‐dose carvedilol in protection against myocardial infarction (MI). Rosuvastatin (RSV) and carvedilol (CAR) were given for 7 consecutive days with concurrent administration of two doses of isoprenaline (ISP) on 6th and 7th days to induce MI. Isoprenaline injections caused detrimental alterations in the myocardial architecture and electrocardiogram (ECG) pattern and significantly increased the infarct size, heart index and serum levels of cardiotoxicity markers compared to the control group. ISP induced oxidative damage, inflammatory and apoptotic events and downregulated PI3K/Akt/Nrf2/HO‐1 signalling pathway compared to the control values. Treatment with low‐dose CAR and/or RSV prevented the ECG and histopathological alterations induced by ISP, and also reduced the infarct size, heart index, serum creatine kinase‐MB, cardiac troponin‐I and C‐reactive protein levels compared to ISP group. CAR and/or RSV treatment restored the activity of superoxide dismutase and total antioxidant capacity with a consequent reduction in lipid peroxides level. Further, they decreased the expression of nuclear factor (NF)‐κB (p65) and increased the phosphorylated PI3K and Akt, which may activate the anti‐apoptotic signalling as evidenced by the decreased active caspase 3 level. The combination therapy has a more significant effect in the most studied parameters than their monotherapy, which may be because of the activation of PI3K/Akt Nrf2/HO‐1 pro‐survival signalling pathway. This study highlights the potential benefits of combining RSV with low‐dose CAR in case of MI.